- Current report filing (8-K)
2010年6月15日 - 6:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported)
June 8, 2010
InfoLogix, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
|
|
333-125575
|
|
20-1983837
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
101 E. County Line Road, Hatboro, Pennsylvania
|
|
19040
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(215) 604-0691
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On June 8, 2010, InfoLogix, Inc. (InfoLogix), through its wholly-owned subsidiary Embedded Technologies, LLC (together with InfoLogix, the Company), entered into a patent purchase agreement (the Agreement) to sell its U.S. and South Korean patents titled Touch Screen Systems and Methods and to assign certain related rights to Intellectual Ventures Fund 68 LLC (IVF) for $2.2 million. The effective date of the Agreement is June 3, 2010 (the Effective Date) and contains customary representations, warranties and covenants. The Company expects the sale of the patents and assignment of related rights to close within 30 days of the Effective Date (the Closing).
At Closing, IVF will grant the Company a royalty-free, non-exclusive, non-sublicensable, non-transferable right and license to practice the methods covered by the patents and to make, use, distribute, lease, sell, offer for sale, import, export, develop and otherwise dispose of and exploit any of the Companys products covered by the patents.
2
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INFOLOGIX, INC.
|
|
|
|
|
|
|
Date: June 14, 2010
|
By:
|
/s/ John A. Roberts
|
|
|
John A. Roberts
|
|
|
Chief Financial Officer
|
3
Infologix (MM) (NASDAQ:IFLG)
過去 株価チャート
から 5 2024 まで 6 2024
Infologix (MM) (NASDAQ:IFLG)
過去 株価チャート
から 6 2023 まで 6 2024